Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 6/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 4/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | HTR2C | P28335 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | HRH1 | P35367 | 1/20 | 0.38 |
| ▸ | DRD3 | P35462 | 1/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6722543 | 0.89 | — | — | |
| SCHEMBL6724909 | 0.88 | — | — | |
| SCHEMBL7712354 | 0.85 | SLC1A3 (0.42) | CA2MAPK1CA1TSHRUSP2 | |
| SCHEMBL1920046 | 0.85 | CA2 (0.64) | CA2MAPK1CA1USP2SLC1A3 | |
| SCHEMBL7509585 | 0.83 | CA2 (0.45) | CA2MAPK1CA1TSHRUSP2 | |
| SCHEMBL8799307 | 0.83 | CA2 (0.56) | CA2MAPK1CA1SLC1A2SLC1A1 | |
| SCHEMBL5711132 | 0.81 | CA2 (0.54) | CA2MAPK1CA1SLC1A2SLC1A1 | |
| SCHEMBL22612302 | 0.81 | CA2 (0.54) | CA2MAPK1CA1SLC1A2SLC1A1 | |
| SCHEMBL6580213 | 0.81 | CA2 (0.54) | CA2MAPK1CA1SLC1A2SLC1A1 | |
| SCHEMBL5698797 | 0.81 | CA2 (0.54) | CA2MAPK1CA1SLC1A2SLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6369269-B2 | Thiol and sulfur-containing O-(meth)acrylate compounds and use thereof | MITSUI CHEMICALS, INC. (JP) | 2002-04-09 | — | — | US | disclosed |
| US-20010044555-A1 | Thiol and sulfur-containing O-(meth)acrylate counpounds and use thereof | KOBAYASHI SEIICHI (JP) | 2001-11-22 | — | — | US | disclosed |
| US-6265510-B1 | OPTICS; LENSES | MITSUI CHEMICALS, INC. (JP) | 2001-07-24 | — | — | US | disclosed |
| EP-0810210-B1 | Thiol and sulfur-containing o-(meth)acrylate compounds and use thereof | MITSUI CHEMICALS INC (JP) | 2001-01-10 | — | — | EP | disclosed |
| US-6114485-A | STARTING MATERIAL FOR A RESIN COMPOSITION USED IN OPTICAL APPLICATIONS SUCH AS A LENS | MITSUI CHEMICALS, INC. (JP) | 2000-09-05 | — | — | US | disclosed |
| US-5916987-A | OPTICAL RESIN; LENSES | MITSUI CHEMICALS, INC. (JP) | 1999-06-29 | — | — | US | disclosed |
| EP-0810210-A2 | Thiol and sulfur-containing o-(meth)acrylate compounds and use thereof | MITSUI TOATSU CHEMICALS, INC. (JP) | 1997-12-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010044555-A1 | Thiol and sulfur-containing O-(meth)acrylate counpounds and use thereof | MSRB3, BHMT2, HBS1L | CA2 3074/4885MAPK1 2485/4885CA1 3024/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.